TrialMedicine2015

A Phase II Study of Gemcitabine, Vincristine, and Cisplatin As Second-Line Treatment for Patients with Advanced Soft Tissue Sarcoma.

Zhiguo Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.